Mechanisms of lung injury after bone marrow transplantation

American Journal of Respiratory Cell and Molecular Biology

Volumn 20, Issue 6, 1999, Pages 1097-1099

  Folz, Rodney J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BONE MARROW TRANSPLANTATION; DISEASE MODEL; HUMAN; LUNG DISEASE; MOUSE; PNEUMONIA; REVIEW;

ANIMALS; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; HUMANS; LUNG DISEASES; MICE; PNEUMONIA;

EID: 0033144463     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.20.6.f152     Document Type: Review

References (20)

1. Chao, N. J., S. J. Forman, G. M. Schmidt, D. S. Snyder, M. D. Amylon, P. N. Konrad, A. P. Nademanee, M. R. O'Donnell, P. M. Parker, and A. S. Stein. 1991. Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission. Blood 78:1923-1927.
2. Enright, H., and P. McGlave. 1998. Bone marrow transplantation for chronic myclogenous leukemia. Curr. Opin. Oncol. 10:100-107.
3. Flinn, I. W., and G. Vogelsang. 1998. Bone marrow transplantation for chronic lymphocytic leukemia. Semin. Oncol. 25:60-64.
4. Walters, M. C., M. Patience, W. Leisenring, J. R. Eckman, J. P. Scott, W. C. Mentzer, S. C. Davies, K. Ohene-Frempong, F. Bernaudin, D. C. Matthews, R. Storb, and K. M. Sullivan. 1996. Bone marrow transplantation for sickle cell disease. N. Engl. J. Med. 335:369-376.
5. Boulad, F., P. Giardina, A. Gillio, N. Kernan, T. Small, J. Brochstein, K. Van Syckle, D. George, P. Szaboles, and R. J. O'Reilly. 1998. Bone marrow transplantation for homozygous beta-thalassemia: the Memorial Sloan-Kettering Cancer Center experience. Ann. NY Acad. Sci. 850:498-502.
6. Hernandez-Boluda, J. C., P. Marin, E. Carreras, J. L. Aguitar, A. Granena, C. Rozman, and E. Montserrat. 1999. Bone marrow transplantation for severe aplastic anemia: the Barcelona hospital clinic experience. Haematologica 84:26-31.
7. Brodsky, R. A., and B. D. Smith. 1999. Bone marrow transplantation for autoimmune diseases. Curr. Opin. Oncol. 11:83-86.
8. Wang, B., Y. Yamamoto, N. S. El-Badri, and R. A. Good. 1999. Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice. Proc. Natl. Acad. Sci. USA 96:3012-3016.
9. Peters, W. P., M. Ross, J. J. Vredenburgh, B. Meisenberg, L. B. Marks, E. Winer, J. Kurtzberg, R. C. Bast, Jr., R. Jones, E. Shpall, K. Wu, G. Rosner, C. Gilbert, B. Mathias, D. Coniglio, W. Petros, I. C. Henderson, L. Norton, R. B. Weiss, D. Budman, and D. Hurd. 1993. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J. Clin. Oncol. 11:1132-1143.
10. Clark, J. G., J. A. Hansen, M. I. Hertz, R. Parkman, L. Jensen, and H. H. Peavy. 1993. Idiopathic pneumonia syndrome after bone marrow transplantation. Am. Rev. Respir. Dis. 147:1601-1606.
11. Wilczynski, S. W., J. J. Erasmus, W. P. Petros, J. J. Vredenburgh, and R. J. Folz. 1998. Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer. Am. J. Respir. Crit. Care Med. 157:565-573.
12. Weiner, R. S., M. M. Boymer, R. P. Gale, E. Gluckman, H. E. M. Kay, H.-J. Kolb, A. J. Hartz, and A. A. Rimm. 1986. Interstitial pneumonitis after bone marrow transplantation. Ann. Intern. Med. 104:168-175.
13. Cherniack, R. M., J. Abrams, and A. R. Kalica. 1994. Pulmonary disease associated with breast cancer therapy. Am. J. Respir. Crit. Care Med. 150:1169-1173.
14. Shankar, G., J. S. Bryson, C. D. Jennings, P. E. Morris, and D. A. Cohen. 1998. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation. Am. J. Respir. Cell Mol. Biol. 18:235-242.
15. Shankar, G., J. S. Bryson, C. Darrell Jennings, Alan M. Kaplan, and Donald A. Cohen. 1999. Idiopathic pneumonia syndrome after allogeneic bone marrow transplantation in mice: role of pretransplant radiation conditioning. Am. J. Respir. Cell Mol. Biol. 20:1116-1124.
16. Panoskaltsis-Mortari, A., P. A. Taylor, T. M. Yaeger, O. D. Wangensteen, P. B. Bitterman, D. H. Ingbar, D. A. Vallera, and B. R. Blazar. 1997. The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide. J. Clin. Invest. 100: 1015-1027.
17. Haddad, I. Y., A. Panoskaltsis-Mortari, D. H. Ingbar, S. Yang, C. E. Milla, and B. R. Blazar. 1999. High levels of peroxynitrite are generated in the lungs of irradiated mice given cyclophosphamide and allogeneic T cells: a potential mechanism of injury after marrow transplantation. Am. J. Respir. Cell Mol. Biol. 20:1125-1135.
18. Cooper, J. A., Jr., W. W. Merrill, and H. Y. Reynolds. 1986. Cyclophosphamide modulation of bronchoalveolar cellular populations and macrophage oxidative metabolism: possible mechanisms of pulmonary pharmacotoxicity. Am. Rev. Respir. Dis. 134:108-114.
19. van der Vliet, A., J. P. Eiserich, B. Halliwell, and C. E. Cross. 1997. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite: a potential additional mechanism of nitric oxide-dependent toxicity. J. Biol. Chem. 272:7617-7625.
20. Todd, N. W., W. P. Peters, A. H. Ost, V. L. Roggli, and C. A. Piantadosi. 1993. Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantation. Am. Rev. Respir. Dis. 147:1264-1270.